Log In
BCIQ
Print this Print this
 

Cetraxal Plus, Ciprofloxacin plus fluocinolone otic solution (Duoxal)

  Manage Alerts
Collapse Summary General Information
Company Laboratorios Salvat S.A.
DescriptionCiprofloxacin 0.3% plus fluocinolone 0.025% otic solution
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationOtitis media
Indication DetailsTreat acute otitis media (AOM) associated with tympanostomy tubes; Treat otitis externa
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

0

0


 Deals Details
Get a free BioCentury trial today